Frequency of GABAB receptor antibodies in limbic encephalitis and GAD antibody-associated neurological disorders GABAB receptor antibodies (GABABR-ab) have been recently described in patients with limbic encephalitis (LE), associated with small cell lung cancer (SCLC) or with concurrent glutamic acid decarboxylase (GAD) antibodies.